Zydus Lifesciences launches Rexigo in India; shares up
Zydus's advanced prostate cancer drug Rexigo works by suppressing testosterone30-01-2024
30-01-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023
ZYDUS WELLNESS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended on December 31, 202329-01-2024
Zydus Gets U.S.FDA Nod For Generic Medication
Zydus Lifesciences on Thursday said it has received approval from the U.S. health regulator to market a generic medication to manage postherpetic neuraliga.25-01-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Regulation 39(3) of the SEBI (LODR) Regulations, 201523-01-2024
Zydus Lifesciences subsidiary signs licensing agreement with Synthon BV
Zydus Lifesciences stock edges up on NSE19-01-2024
Zydus gets USFDA's nod for antipsychotic drug, stock flat
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis.18-01-2024
Zydus Group To Invest Rs 5,000 Crore In Gujarat
Zydus Group on Friday announced plans to invest Rs 5,000 crore in Gujarat in various sectors, including new generation biotechnology products and hospitals, its Chairman Pankaj Patel said.12-01-2024
Neutral Zydus Lifesciences; target of Rs 710: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus Lifesciences with a target price of Rs 710 in its research report dated January 09, 2024.10-01-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Receipt Of Order Under CGST Act, 2017
Receipt of Order under CGST Act, 201708-01-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication with regard to Notice to the shareholders for transfer of shares to IEPF06-01-2024